Crane Biosciences

Active

Red blood cell-derived nanoparticle platform for brain mRNA delivery.

What it does

Crane Biosciences engineers red blood cell–based nanoparticles to transport nucleic acid therapeutics across the blood-brain barrier—supporting precise, minimally invasive delivery for neurological diseases.